A new imaging approach reveals how dual agonist drugs like tirzepatide act on the pancreas and brain to regulate blood sugar and appetite. Using fluorescent probes called daLUXendins, researchers visualized drug binding to insulin-producing beta cells and other pancreatic cell types, as well as brain regions tied to hunger regulation.
